PropertyValue
?:abstract
  • This International Alliance for Biological Standardization COVID-19 webinar was organized to provide an update on the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2, none months after COVID-19 was declared a public health emergency of international concern. It brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries.
is ?:annotates of
?:creator
?:doi
  • 10.1016/j.biologicals.2020.11.003
?:doi
?:journal
  • Biologicals
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/36aeb44954fea7977e4759167ec92898631786fc.json; document_parses/pdf_json/af028c0868b25e2675517bf251797af3c5300fa7.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7676373.xml.json
?:pmcid
?:pmid
?:pmid
  • 33234420.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic
?:type
?:year
  • 2020-11-19

Metadata

Anon_0  
expand all